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Abstract
Severe pediatric sepsis continues to be associated with high mortality rates in children. Thus, an important area of
biomedical research is to identify biomarkers that can classify sepsis severity and outcomes. The complex and
heterogeneous nature of sepsis makes the prospect of the classification of sepsis severity using a single biomarker less
likely. Instead, we employ machine learning techniques to validate the use of a multiple biomarkers scoring system to
determine the severity of sepsis in critically ill children. The study was based on clinical data and plasma samples provided
by a tertiary care center’s Pediatric Intensive Care Unit (PICU) from a group of 45 patients with varying sepsis severity at the
time of admission. Canonical Correlation Analysis with the Forward Selection and Random Forests methods identified a
particular set of biomarkers that included Angiopoietin-1 (Ang-1), Angiopoietin-2 (Ang-2), and Bicarbonate (HCO3) as having
the strongest correlations with sepsis severity. The robustness and effectiveness of these biomarkers for classifying sepsis
severity were validated by constructing a linear Support Vector Machine diagnostic classifier. We also show that the
concentrations of Ang-1, Ang-2, and HCO3 enable predictions of the time dependence of sepsis severity in children.
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Introduction
Pediatric sepsis continues to be a very significant cause of
mortality in children [1,2]. Patients who develop organ dysfunc-
tion (i.e. severe sepsis or septic shock) have worse morbidity and
mortality compared to those who do not [3,4]. Diagnosing and
classifying the severity of sepsis is a significant challenge due to the
highly variable and nonspecific nature of the signs and symptoms
of sepsis. Biomarkers that play critical roles in the disease process
show great promise in indicating the severity of sepsis. There are
many biomarkers that have been studied for potential use in the
early diagnosis and classification of sepsis [5,6]. However the
complex and heterogeneous nature of sepsis makes the prospect of
single biomarker classification less likely.
No single biomarker has sufficient specificity or sensitivity to be
routinely employed in clinical practice. A combination of several
sepsis biomarkers may be more effective, as has been suggested by
other investigators [7–9]. Multivariate methods have the advan-
tage of selecting an optimal subset of variables from a large
number of variables and taking into account the relationship
among the selected variables based on a specific outcome.
In this manuscript, we employ a discovery-oriented approach to
identify a panel of diagnostic biomarkers. We systematically
evaluate many commonly obtained clinical parameters and
laboratory values using the multivariate diagnostic capacity of a
scoring system that incorporates 17 potential variables to classify
patients admitted to a tertiary care center’s Pediatric Intensive
Care Unit (PICU) with or without sepsis (PICU/sepsis group)
versus those with severe sepsis (PICU severe sepsis group).
Materials
Study population
This study was approved by the Pediatric Protocol Review
Committee and the Human Investigation Committee at Yale
University School of Medicine. Patient records were anonymized
and de-identified prior to analysis. The biological specimens and
clinical data sets were obtained from a prospective observational
study of critically ill pediatric patients with varying degrees of
sepsis severity conducted at a tertiary care center PICU during the
time period 9/2009–12/2011 [10].
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All patients admitted to the PICU were evaluated for eligibility.
Forty-five patients met the eligibility criteria and consented to
participate in the study. Using the 2005 pediatric sepsis and organ
dysfunction definitions [11], patients were divided into one of five
categories based on clinical exam findings in the first 24-hours of
PICU admission. The categories included systemic inflammatory
response syndrome (SIRS), non-SIRS, sepsis, severe sepsis and
septic shock. Briefly, SIRS required the presence of at least two of
the following four criteria with one being abnormal temperature
or leukocyte cout: abnormal core temperature, mean respiratory
rate, leukocyte count, or tachycardia. Non-SIRS patients were
admitted to the PICU but did not meet SIRS criteria. Patients
with sepsis fulfilled SIRS criteria with suspected or proven
infection. Patients with severe sepsis met the criteria for sepsis
with organ failure, and septic shock patients were a subset of the
severe sepsis group with cardiovascular organ failure [11]. Blood
samples were collected every 12 hours for the first 3 days and then
once a day for the last 4 days. Data collection was discontinued
when the patient was discharged from the PICU. A maximum of
10 samples for 7 days were obtained from each patient. As a result
of PICU discharge and line removal, the total number of samples
available for analysis decreased with time for all patient groups.
The number of samples for each time point is shown in Figure S1.
Commercial enzyme-linked immunosorbent assay (ELISA) kits
were used to measure plasma levels of Ang-1 and Ang-2.
Descriptive data consisting of demographics and clinical data for
all patients included in the clinical studies are provided in Tables
S1 and S2 in File S1. Additional details can be found in Text S1 in
File S1 and Ref. [10].
Biomarkers
To create a robust model of a specific combination of
biomarkers for predicting the severity of sepsis in children in an
unbiased manner, we selected multiple clinical and laboratory
variables from the database of our study [10]. These 17 variables
are as follows: (1) Age, (2) Weight (Wgt), (3) admission Pediatric
Index of Mortality 2 (PIM-2) [12], (4) White Blood Cell count
(WBC), (5) Hemoglobin count (Hgb), (6) Hematocrit (Hct), (7)
Platelet count (Plt), and the levels of (8) Sodium (Na), (9) Potassium
(K), (10) Chloride (Cl), (11) HCO3, (12) Blood Urea Nitrogen
(BUN), (13) Creatinine (Cr), (14) Ang-1, (15) Ang-2, (16) Ang-2/
Ang-1 ratio, and (17) Vascular Endothelial Growth Factor
(VEGF). To validate the data analysis, we augmented this data
set to include (18) Gaussian distributed noise (g-Noise) and (19)
uniformly distributed noise (u-Noise). These 19 variables were
then used to develop sepsis severity prediction models.
Statistical analysis
Patients were classified within the first 24 hours of PICU
admission into the five categories listed above based on the 2005
pediatric sepsis and organ dysfunction definitions [11]. We further
consolidated these into the following two categories: 1) the PICU/
sepsis group (n~28) included those not meeting SIRS criteria but
were admitted to the PICU (non-SIRS) (n~9), SIRS (n~8), and
sepsis (n~11); and 2) the PICU severe sepsis group (n~17)
included those with severe sepsis (n~3), and septic shock (n~14).
For the original study listed in Ref. [10], a two-sided Mann-
Whitney test estimated a sample size of 50 (10 patients per group)
to detect 1.5–1.8 standard deviations in the level of Ang-2 between
comparison groups, assuming a standard deviation of 1,500
pg/mL, power of 80%, and a significance level (alpha) of 0.05.
Methods
Data Preprocessing
Our dataset (input), a n|p real-valued matrix x, contains
n~45 attributes and p~19 biomarkers. Since the range of values
of the biomarkers varies widely, it should be normalized so that
each biomarker contributes approximately proportionately. We
normalized x to have zero mean and unit standard deviation for
each biomarker [13]:
xnorm~
x{x
s(x)
, ð1Þ
where xnorm is a n|p matrix, x and s(x) are the mean value and
standard deviation of x for each biomarker. We also assigned each
attribute i~1, . . . ,n, a sepsis severity score, yi. yi~{1 is given to
each in the PICU/sepsis group and yi~z1 for the PICU severe
sepsis group.
Canonical correlation analysis
CCA finds linear combinations of variables between two sets of
data, x and y in our study, which have maximum correlation with
each other [14,15]. Here we selected the optimal subset of
biomarkers x that has the maximum correlation with y for
k~1, . . . ,p, by calculating the correlations between all possible
k-combinations of x and y. The results are displayed in Table 1.
Linear support vector machines
In machine learning, a linear support vector machine (SVM) is
a learning model used for classfication and regression analysis [16].
A SVM model separates two categories by a hyper-plane that has
maximum margin for a given training dataset. New attributes are
predicted to belong to a category based on which side of the hyper-
plane they fall on.
The hyper-plane can be described by the equation:
f (xi)~w
Txi{b, ð2Þ
where w is the normal vector to the hyper-plane, b is the offset of
the hyper-plane from the origin, and xi is a p-dimensional vector
of normalized biomarker values for attribute i in our study. The
search of this hyper-plane can be translated into the following
optimization problem:
Minimize EwE1zCz
P
i:yi~z1
jizC{
P
j:yj~{1
jj
subject    to
wTxizbzji§1, yi~z1,
wTxjzb{jjƒ{1, yj~{1, and
j§0,
ð3Þ
where EwE1~
P
i Dwi D is the 1-norm of a vector, which induces the
sparsity in the weight vector w [17]. The slack variable, ji,
measures the degree of misclassification of xi. The parameters Cz
and C{, which determine the penalty assigned to the total error
from misclassified samples, are chosen so that Cz=C{ is given by
the ratio of the number of negative and positive training
evaluations with C{ =1.0.
Ensemble method
Due to the limited size and noise of our data, we follow the
training procedure in Ref. [18]. A random one-third of the data is
Ang1, Ang2 and HCO3 as Diagnostic Biomarkers in Children Severe Sepsis
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selected as test set, T . The remaining data is used as training set,
L. Bagging is used to construct the classifiers ensemble. Each new
training set, Li, is drawn, with replacement, from the original
training set, L. Then a classifier, SVM or tree, is constructed on
this new training set, Li. In this study, we construct a classifiers
ensemble 50 times, i[f1, . . . ,50g. The final classification is
obtained by calculating the mean of the ensemble of 50 classifiers.
This procedure is repeated 100 times and statistical measures on T
are averaged.
Calculation of statistical measures
TPR, TNR, NPV, and PPV are statistical measures of the
predictive performance of a binary classification test. TPR (or
sensitivity) measures the proportion of actual positives that are
correctly identified. TNR (or specificity) measures the proportion
of actual negatives that are correctly identified. PPV (or precision)
measures the proportion of positives that are true positive. NPV
measures the proportion of negatives that are true negatives.
These statistical measures are calculated for each one of the 100
random divisions of test sets T by the classifier built on the
bootstrap aggregation method. Their mean and standard error are
calculated from the groups obtained from the 100 random
divisions.
Results
Biomarkers selection
Feature selection is an important part of the data analysis given
the fact that the data contains many redundant or irrelevant
features. Redundant features provide no additional information
than the selected features, and irrelevant features provide no useful
information. Feature selection is widely used in data sets with
abundant features but comparatively few samples. In machine
learning and statistics, the goal of a feature selection method is to
select an optimal subset of relevant features for model construc-
tion.
In this study, there are 17 variables (features) augmented by 2
variables consisting of Gaussian and uniform noise to provide a
baseline check for the data analysis. From the univariate
correlation analysis, we found that this data set contained several
possible redundant biomarkers and, not surprisingly, at least two
irrelevant features (g-Noise and u-Noise). To extract an optimal
subset of biomarkers, we analyzed the multivariate correlation
between the outcome, sepsis severity score (0 for PICU/sepsis and
1 for PICU severe sepsis), and the input, which is a subset of
variables.
A comparison of the univariate correlations for these two groups
is shown in Fig. 1. The univariate analysis revealed that Na, K, Cl,
HCO3 form a group of highly correlated biomarkers (with
correlations that range from 0.937 to 0.998) for the PICU/sepsis
group. However, these variables are not strongly correlated for the
PICU severe sepsis group (with correlations that range from 0.001
to 0.608). This notable difference between the PICU/sepsis and
PICU severe sepsis groups indicates that these biomarkers may not
independently provide information about the sepsis severity
diagnosis. We also note that Ang-1 and Ang-2 are highly
correlated with each other in the PICU severe sepsis group
(0.76), but this correlation is significantly reduced for the PICU/
sepsis group (0.21). Meanwhile, Ang-2/Ang-1 does not correlate
very strongly with either Ang-1 (0.21 in PICU/sepsis, 0.24 in
Table 1. Stepwise Biomarker Selection using Canonical Correlation Analysis, Forward Selection and Random Forests.
Dim Corr Entering Leave Forward Selection Random Forests
1 0.3811 Ang-2 Ang-2 Ang-2/Ang-1
2 0.4772 Ang-1 Ang-1 HCO3
3 0.5501 HCO3 HCO3 Ang-2
4 0.5842 Plt Plt Ang-1
5 0.6079 Age Age Cl
6 0.6183 Cl WBC PIM-2
7 0.6221 BUN, Hct, WBC Cl, HCO3 Hct Age
8 0.6286 VEGF BUN K
9 0.6311 PIM-2 VEGF Hgb
10 0.6359 Cl, HCO3 PIM-2 PIM-2 VEGF
11 0.6395 Cr, Wgt Age g-Noise Wgt
12 0.6409 Hgb, Na, Age Cl, Wgt Cl Na
13 0.6414 Ang-2/Ang-1 Cr g-Noise
14 0.6419 Wgt u-Noise Plt
15 0.6424 PIM-2 Ang-2/Ang-1 WBC
16 0.6427 Cl, u-Noise Na Hgb u-Noise
17 0.6429 K Wgt Cr
18 0.6429 Na, g-Noise K K BUN
19 0.6430 K Na Hct
We apply Canonical Correlation Analysis for all possible k-combinations (k~1, . . . ,19) to determine the subset of k biomarkers with the highest correlation with the
sepsis severity score. The ‘Enter’ column indicates the biomarker that is added to achieve the highest correlation at each k. The ‘Leave’ column indicates the biomarker
that is eliminated from the combination at each k. A biomarker will stay in the combination until it occurs in ‘Leave’ column. The ‘Forward Selection’ column gives the
biomarker selected by the Forward Selection method when applied one biomarker at a time. The ‘Random Forests’ column gives the biomarker ranked by the mean
decrease in accuracy measured by the Random Forests method.
doi:10.1371/journal.pone.0108461.t001
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PICU severe sepsis) or Ang-2 (0.48 in PICU/sepsis, 0.17 in PICU
severe sepsis). Based on these observations, we seek to identify an
optimal set of non-redundant variables and biomarkers to predict
the severity of sepsis.
In our recent study [19], we found that canonical correlation
analysis (CCA) [14,15,20] can be applied effectively to identify an
optimal subset of biomarkers with the maximum correlation with
the outcome. As shown in Table 1, we found that the subset of
Ang-2, Ang-1, and HCO3 maximizes the correlation with the
sepsis severity score. As expected, the two forms of random noise
are selected near the end of the process when the correlation
saturates for large subsets. We also applied the forward selection
(FS) method to identify the optimal subset of biomarkers. FS is a
greedy algorithm that adds the best feature at each step [21,22].
We found that the performance of the subset of biomarkers
selected by FS was similar to that selected by CCA on this data set.
The optimal subset
In this study, we built a diagnostic classifier by selecting the
subset of k biomarkers with the best diagnostic performance for
each value of k. For each k, we applied the ensemble method
[18,23] to construct a linear support vector machine (SVM)
classifier [24] for the CCA-selected subset of biomarkers. SVM
[17] finds a decision function that separates the high-dimensional
data with the maximum margin. To quantify the classifier
performance, we calculated the true positive rate (TPR), true
negative rate (TNR), positive predictive value (PPV), and negative
predictive value (NPV). See the Methods section for details.
In Figure 2, we find that all statistical measures reach a peak or
saturate near k~3 using the CCA-selected biomarkers, Ang-2,
Ang-1, and HCO3, which suggests that these three biomarkers are
the optimal subset for our data set (TPR~0:69, TNR
~0:87, PPV~0:79, and NPV~0:83 at k~3). By adding HCO3
to the optimal subset from k~2 to k~3, the combination has
higher TPR (0.60 at k~2 versus 0.69 at k~3) and PPV (0.69 at
k~2 versus 0.79 at k~3) when compared to the combination of
Ang-2 and Ang-1. TNR (0.84 at k~6 versus 0.80 at k~7) and
PPV (0.75 at k~6 versus 0.69 at k~7) begin to decrease from
their plateau values when HCO3 leaves the subset at k~7. The
improvement at k~3 and decrease at k~7 indicate the diagnostic
importance of HCO3.
Redundant biomarkers
Recent studies [10,25–27] suggest that plasma levels of Ang-2
and Ang-1 can serve as clinically informative biomarkers of sepsis
severity. Further, the Ang-2/Ang1 ratio is considered to be a more
relevant sepsis severity biomarker than isolated levels of each
biomarker because of their antagonistic roles in regulating the
tyrosine kinase receptor, Tie-2 [27]. However, both of our
biomarker selection methods, CCA and FS, select Ang-2/Ang-1
to the optimal subset relatively late, i.e., at large k (k~13 and
k~15) as shown in Table 1. This suggests that a combination of
Ang-2, Ang-1, and HCO3, is potentially more effective than using
the ratio of Ang-1 and Ang-2 with other biomarkers.
It is also interesting to consider the univariate and bivariate
performance of these biomarkers. This analysis provides additional
insight into the relative performance of different subsets of
biomarkers and how they work together to provide inferences.
In Fig. 3(A), the relative performance of the univariate
biomarkers performance is shown: 1) Ang-1 has consistent
performance for all statistical measures compared to other
biomarkers (see Table 2), 2) Ang-2 has a high TNR (0.85) and
PPV (0.63) but relatively low TPR (0.38), and 3) HCO3 has the
highest TPR (0.87) and NPV (0.86) but relatively low TNR (0.42)
and PPV (0.48). These observations indicate that the performances
of these biomarkers did not correlate with each other. This
supports the observation that the best subset of biomarkers
includes both Ang-1 and Ang-2 since they provide distinct
information. We also show that the combination of Ang-2, Ang-
1 and HCO3 improves the predictive capability by reducing
overfitting in Fig. 2. The performance for the CCA-selected
subsets decreases when kw3.
These results suggest, when examining groups of three, Ang-2/
Ang-1 may be a redundant biomarker, i.e., no additional
information is gained when Ang-1 and Ang-2 data is known.
We explore here how this ratio performs in isolation, i.e., as a
derived univariate statistic. We applied the same procedure as
above to construct a SVM classifier for each single biomarker and
Figure 1. Heatmaps of pairwise correlations. Heatmaps of all pairwise correlations between the 17 variables (plus two noise samples) for
patients in the (A) PICU/sepsis and (B) PICU severe sepsis groups. The color scale from blue to red indicates increasing correlations between the pair
of biomarkers at the corresponding locations on the horizontal and vertical axes.
doi:10.1371/journal.pone.0108461.g001
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show the statistical measures in Fig. 3(A). Overall, we find that
Ang-2 and Ang-2/Ang-1 have comparable prediction perfor-
mance (Fig. 3(A)). However, Ang-2/Ang-1 outperforms Ang-2 for
PPV (0.76 for Ang-2/Ang-1, 0.63 for Ang-2), which suggests that
Ang-2/Ang-1 alone may be a predictive biomarker. The similar
performance of Ang-2 and Ang-2/Ang-1 suggest that these two
biomarkers capture very similar information.
Of course it is not necessarily a fair assessment to compare true
univariate biomarkers such as Ang-1 and Ang-2 to their ratio since
this contains information from two measurements. Thus, we also
compared the performance of combinations of Ang-1, Ang-2,
HCO3, and Ang-2/Ang-1 in Fig. 3(B). The combination of Ang-2
and Ang-2/Ang-1 does not notably improve each predictive
measure compared to these biomarkers alone, which also indicates
that these two biomarkers are redundant. In contrast, the
combination of Ang-1 and Ang-2 has notably higher NPV (0.78)
and TPR (0.60) and comparable values for the other prediction
measures compared to each single biomarker (NPV~0:69 and
TPR~0:38 for Ang-2, NPV~0:57 and TPR~0:48 for Ang-1)
and Ang-2/Ang-1 (NPV~0:67 and TPR~0:35). This suggests
that the ratio Ang-2/Ang-1 is less effective than using Ang-1 and
Ang-2 separately.
For completeness, we also show the performance for the CCA-
selected optimal subset of three biomarkers HCO3, Ang-1 and
Ang-2 on the far right of Fig. 3(B). This optimal subset notably
improves the predictive capability as indicated by the small spread
of values in the predictive measures.
The diagnostic classifier
We applied the linear SVM ensemble method [23,24] to
construct a decision function using the CCA-selected optimal
subset of biomarkers at k~3: Ang-2, Ang-1, and HCO3. The
optimal decision function is
Figure 2. Prediction measures obtained from the Support Vector Machine (SVM) using the k-combinations selected by the
Canonical Correlation Analysis (CCA) and Random Forests (RF) methods. The prediction measures (A) true positive rate (TPR), (B) true
negative rate (TNR), (C) positive predictive value (PPV), and (D) negative predictive value (NPV) are shown for each step k. For each k, a SVM ensemble
with bagging is constructed based on the CCA- and RF-selected subset of biomarkers.
doi:10.1371/journal.pone.0108461.g002
Figure 3. Prediction measures for single and pairs of biomark-
ers from the Support Vector Machine (SVM). True positive rate
(TPR), true negative rate (TNR), positive predictive value (PPV), and
negative predictive value (NPV) are shown for (A) each single biomarker
and (B) all pairwise combinations of Ang-1, Ang-2, HCO3 and Ang-2/
Ang-1. The prediction measures for the CCA-selected optimal subset of
biomarkers at k~3 (Ang-2, Ang-1, and HCO3) are also shown in (B) for
comparison.
doi:10.1371/journal.pone.0108461.g003
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Score~w1Ang-2zw2Ang-1zw3HCO3{b: ð4Þ
Table 3 provides the weights wi, errors ei, means xi and
standard deviations si of the biomarkers. Since the range of values
of the biomarkers varies widely, all values of the biomarkers are
normalized by subtracting the mean and then dividing by the
standard deviation in Eq. 4. See the Methods section for details.
With this decision function, if the sepsis severity score (Score) is
greater than or equal to zero, the severity diagnosis is 1, otherwise
it is 0. The magnitudes of weights wi indicate the importance of
the corresponding biomarker [28]. We find that Ang-2 has a larger
weight than Ang-1 and HCO3, which is consistent with the results
for the single biomarker classification in Fig. 3(A), where the TNR,
and PPV are larger for Ang-2 than Ang-1 and HCO3. However,
the TPR and NPV are larger for HCO3 compared to that for Ang-
2. The sign of each weight wi indicates the sign of the correlation
of the biomarker with the sepsis severity score. Thus, the sepsis
severity score for a patient with a relatively high Ang-2 level and
low Ang-1 and HCO3 levels is most likely positive. This relation
between biomarkers and sepsis severity score has been observed in
clinical studies [25,29,30].
Longitudinal measurements of the predictor
A linear SVM finds the hyper-plane that separates data with
maximum margin by categories. In our study, the sign of the sepsis
severity score (Score) in Eq. 4 can predict the category for a
patient. The magnitude of the Score represents the distance from
the decision boundary and indicates the severity of sepsis. A large
positive Score indicates critical severity.
Based on the fact that patients were hospitalized during the
study, the longitudinal measurements should show a decrease in
the number of patients in the PICU severe sepsis group. Fig. 4
shows that Scores in the PICU severe sepsis group are notably
separated from the PICU/sepsis group for the first two days after
admission. After two days, the Scores in the PICU severe sepsis
group decrease and collapse with those from the PICU/sepsis
group indicating the effectiveness of the treatment. Additionally,
the sepsis severity score (Eq. 4) measured on the first 2 days after
admission may allow for the early identification of patients with
severe sepsis, which is important for the initiation of early goal-
directed therapies.
Comparison with the random forests learning method
Random forests (RF) [31] is an ensemble method [18,23], which
grows multiple classification and regression trees (CART) [32] for
prediction. Every tree in the forests is constructed by a random
selected bootstrap training set with replacement [18]. The splitting
criteria for every decision node in a tree are also chosen from a
random subset of the features without replacement. With the
replacement from the original data, about two-thirds of the
samples are used to construct a tree [18]. The out-of-bag (OOB)
data, which are not chosen in the construction, are then used to
estimate the prediction accuracy and the importance of the
features [31,33]. Unlike a linear SVM, which constructs a hyper-
plane to classify the data, a tree is a hierarchical classification
procedure, which recursively partitions the data to increase the
purity of the nodes with respect to the outcome [32].
RF provides two measures, the mean decrease in accuracy
(MDA) and mean decrease in the Gini index [31,33], to estimate
the importance of the features. In our study, the MDA is chosen to
estimate the feature importance since the decrease in the Gini
index is not as reliable as MDA [33,34]. By randomly permuting
the values of a given feature in the OOB data for each tree, RF
measures the accuracy difference between untouched and
Table 2. Prediction measures for single biomarker from Support Vector Machine.
Variable TPR TNR PPV NPV
Age 0.666 0.555 0.490 0.728
Wgt 0.496 0.636 0.466 0.671
PIM-2 0.276 0.611 0.407 0.524
WBC 0.298 0.192 0.183 0.255
Hgb 0.249 0.076 0.121 0.195
Hct 0.248 0.104 0.126 0.184
Plt 0.636 0.501 0.451 0.697
Na 0.710 0.105 0.297 0.710
K 0.737 0.112 0.309 0.735
Cl 0.570 0.073 0.236 0.570
HCO3 0.868 0.415 0.480 0.865
BUN 0.343 0.358 0.197 0.411
Cr 0.430 0.065 0.177 0.440
Ang-1 0.477 0.457 0.384 0.566
Ang-2 0.378 0.846 0.625 0.690
Ang-2/Ang-1 0.353 0.881 0.760 0.675
VEGF 0.773 0.370 0.424 0.764
g-Noise 0.481 0.251 0.266 0.496
u-Noise 0.461 0.442 0.340 0.564
True positive rate (TPR), true negative rate (TNR), positive predictive value (PPV), and negative predictive value (NPV) are shown for each single variable.
doi:10.1371/journal.pone.0108461.t002
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permuted OOB data. The average of this accuracy difference over
all trees in the forest is the MDA for the given feature. The MDA
is the average increase in misclassification rate due to the
permutations. The larger the MDA the more important the
corresponding feature is with respect to the outcome.
Following Ref. [31], we construct a forest with 1,000 trees to
estimate the MDA for the biomarkers. We generated two RF: one
for which Ang-2/Ang-1 is excluded (Fig. 5(A)) or included
(Fig. 5(B)). Because of the interaction of Ang-2, Ang-1, and Ang-
2/Ang-1, the existence of Ang-2/Ang-1 suppresses the importance
of Ang-2 and Ang-1. However, both CCA and FS methods tend to
select the combination of Ang-2 and Ang-1 as the most predictive
feature. We notice that HCO3 is considered important for all three
methods, which suggests HCO3 is also an important biomarker.
The RF ranked biomarkers based on the importance are also
shown in Table 1.
We also constructed a SVM ensemble using the RF-selected
subset for each step k in Fig. 2 for comparison. Similar to the
CCA-selected subset in Fig. 2, all prediction measures saturate at
k~4 and decrease for kw4. We find that the RF-selected optimal
subset, Ang-2/Ang-1, HCO3, Ang-2, Ang-1 at k~4, have
comparable prediction performance with the CCA-selected
optimal subset at k~3.
Discussion
In this study, we employed machine learning approaches to
analyze the clinical data of children with severe sepsis using feature
selection methods, such as CCA, SVM, FS and RF. Feature
selection methods are helpful in identifying biomarkers with
minimum redundancy that can be useful in clinical diagnosis. Our
multivariate feature selection methods select the combination of
Ang-1, Ang-2, and HCO3 as the optimal biomarkers for our data
set. We demonstrated that this optimal combination of biomarkers
significantly outperformed each single biomarker and all other
combinations with redundant or irrelevant biomarkers for all
statistical measures.
Our work [10,27], and that of others, has shown the biological
plausibility and clinical relevance of Ang-2 and Ang-1 levels in
PICU patients with severe sepsis. It is interesting to note that
combining Ang-2 and Ang-1 with a well-established (and routinely
measured) indicator of an imbalance in the acid-base levels
performs much better than other scoring systems that are more
complex (for example, PIM-2 [12]).
Our data driven approach indicates that there is an optimal set
of biomarkers for diagnosing severe sepsis. We have demonstrated
that the use of additional biomarkers actually reduces the quality
of the diagnostic scoring system. This is a potentially important
observation in the sense that it suggests that more feature rich data
may not be helpful, but actually harmful to patient care.
In addition, a sepsis severity score function (Eq. 4) using this
optimal combination of biomarkers was constructed by the SVM
Table 3. Parameters for the decision function that includes the CCA-selected optimal subset of biomarkers at k~3.
i Biomarker Mean Standard Deviation Weight Standard Error of Weight
xi si wi (b~0:313) ei
1 Ang-2 8518.1 13264 1.994 0.065
2 Ang-1 2649.2 4008.9 21.396 0.050
3 HCO3 27.270 24.361 21.340 0.072
The values of the weights wi , errors ei , means xi , and standard deviations si for the biomarkers in Eq. (4).
doi:10.1371/journal.pone.0108461.t003
Figure 4. Longitudinal measurements of the sepsis severity
score. The sepsis severity scores (Score) for patients from the PICU/
sepsis group and the PICU severe sepsis during the 7 days of illness.
Both the mean and individual severity scores are plotted.
doi:10.1371/journal.pone.0108461.g004
Figure 5. Measures of the biomarker importance obtained
from the Random Forests method. Mean Decrease in Accuracy
(MDA) are shown for biomarkers in (A) without Ang-2/Ang-1 and (B)
with Ang-2/Ang-1 using the Random Forests method with 1,000 trees
for each.
doi:10.1371/journal.pone.0108461.g005
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ensemble method. With this function, we can interpret the relation
between these three biomarkers and the sepsis severity from the
associate weights, wi [28]. Even though these relations have been
observed in clinical studies [10,25,26], we assert that our
methodology is useful since it obtains similar results to those of
the clinical studies using unbiased, rigorous statistical analyses. It
also holds promise for the discovery of novel biomarkers.
The proposed sepsis severity score for each sample is also
evaluated during the treatment. The patients in the PICU severe
sepsis group have significantly high severity scores after admission.
The sepsis severity scores measured on the first 2 days after
admission may allow for the early identification of patients with
severe sepsis. After two days treatment, the severity scores for each
patient decline and collapse to match patients without severe
sepsis. Based on the fact that all patients survived hospitalization,
the change in the longitudinal measurements of this score function
validates the robustness and effectiveness of this function as
regards its potential utility at different stages of treatment.
It has been observed that single biomarkers, in isolation, have
limited diagnostic capacity [5]. This study supports this conclu-
sion. Our analysis strongly supports the conclusion that a
combination of different biomarkers is more effective, i.e., using
multiple biomarkers for diagnosis is superior to drawing conclu-
sions from single biomarkers. The rationale for this observation
may be that the biomarkers are not independent of each other but,
as we have shown with our canonical correlation analysis, are
correlated in groups. The identification of an optimal combination
of biomarkers allows clinicians to focus on a small subset of
indicators, which simplifies the diagnosis of sepsis in children with
a spectrum of severities.
Despite the success in the classification of sepsis severity for this
patient group, our study has several limitations. First, the data set
was obtained from a single institution making generalizability
difficult. Second, the biomarkers used to construct our models
were based on clinical availability for most patients. It is possible
that additional biomarkers, such as cytokines, would have
improved the statistical measures for our models. Finally, since
we have shown that measures of acid-base status are predictive
biomarkers, it is likely that other acid-base determinants from
blood gas analyses will also be predictive biomarkers. However,
blood gas results were only available for the severe sepsis group
(not other groups), and thus including blood gas measurements
would have biased our findings. We advocate new clinical studies
that include additional clinical variables, such as blood gas panels,
to address the question of finding the most predictive set of
biomarkers for severe sepsis.
In conclusion, we have shown that a linear additive combina-
tion of 3 biomarkers, namely Ang-2, Ang-1 and HCO3 provides a
robust prediction of sepsis severity in patients admitted to the
PICU. Additional independent studies are needed to confirm or
refute the clinical utility of our biomarker combination for sepsis
severity prediction. The collection of data sets with larger sample
sizes would also be very useful for validating our statistical study.
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Figure S1 Sample size by study day. Samples were obtained
twice per day for the first 3 days and then once per day for the last
4 days, for a maximum of 7 days and 10 samples. Sample
collection was discontinued when the patient was discharged from
the PICU, after the 7-day study completion, or when the clinical
team deemed it unnecessary to draw further labs for patient care.
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organisms isolated in patients. N gives the number of patients with
a given proven infection. Table S2, Baseline patient characteris-
tics: Statistical analysis of the baseline patient characteristics based
on the evaluation distributions of the PICU/sepsis group and
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count (percentage), were analyzed using Fisher exact test.
Continuous variables, presented as mean (standard deviation),
were analyzed using the two-tailed t test. P values are comparisons
between two groups. Any significance level of P less than 0.05 is
associated with the diagnosis. Text S1, Supplementary Text.
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